Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumors Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT00093678
What this trial is testing

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Who this might be right for
CachexiaLymphomaMelanoma (Skin)+4 more
Eastern Cooperative Oncology Group
Early research (Phase 1)UnknownNCT04651348
What this trial is testing

A Clinical Study of MIL95 in Advanced Malignancies.

Who this might be right for
Advanced Malignancies
Beijing Mabworks Biotech Co., Ltd. 58
Testing effectiveness (Phase 2)Looking for participantsNCT04094610
What this trial is testing

Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1 more
Turning Point Therapeutics, Inc. 75
Early research (Phase 1)Study completedNCT00345189
What this trial is testing

Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors

Who this might be right for
TumorsLymphoma
Biogen 70
Testing effectiveness (Phase 2)Study completedNCT00002691
What this trial is testing

Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT07215910
What this trial is testing

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Who this might be right for
Astrocytoma, IDH-Mutant, Grade 3
Alliance for Clinical Trials in Oncology 408
Testing effectiveness (Phase 2)Looking for participantsNCT05969860
What this trial is testing

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Who this might be right for
Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more
Mayo Clinic 220
Testing effectiveness (Phase 2)Looking for participantsNCT07222631
What this trial is testing

SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas

Who this might be right for
Non Hodgkin LymphomaSolid Tumor
University of California, San Diego 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT03698994
What this trial is testing

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Ependymal TumorRecurrent Ewing Sarcoma+33 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT04282018
What this trial is testing

Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaFollicular Lymphoma+4 more
BeiGene 97
Early research (Phase 1)Study completedNCT04306224
What this trial is testing

IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas

Who this might be right for
Solid TumorLymphoma
ImmuneOncia Therapeutics Inc. 12
Early research (Phase 1)Study completedNCT00923520
What this trial is testing

A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies

Who this might be right for
Renal Cell CarcinomaBreast CancerColon Cancer+2 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT04338659
What this trial is testing

A Phase 1a Study Evaluating the Safety, Tolerability, and Efficacy of IBI322 in Subjects With Advanced Cancers

Who this might be right for
Advanced Malignant Tumors Lymphomas
Innovent Biologics (Suzhou) Co. Ltd. 22
Early research (Phase 1)Study completedNCT03458117
What this trial is testing

T-VEC in Non-melanoma Skin Cancer

Who this might be right for
Non-melanoma Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma+2 more
University of Zurich 26
Testing effectiveness (Phase 2)Looking for participantsNCT06292208
What this trial is testing

A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors

Who this might be right for
MTD
SUNHO（China）BioPharmaceutical CO., Ltd. 48
Early research (Phase 1)Looking for participantsNCT06022029
What this trial is testing

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Who this might be right for
Triple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more
OncoNano Medicine, Inc. 168
Early research (Phase 1)UnknownNCT05296772
What this trial is testing

Phase 1 First-in-human Study of JS014

Who this might be right for
Neoplasm MalignantNeoplasm, ExperimentalSolid Tumor, Adult+1 more
Anwita Biosciences 60
Early research (Phase 1)Study completedNCT01359982
What this trial is testing

Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects

Who this might be right for
Malignant Solid TumorLymphomas
EpicentRx, Inc. 26
Early research (Phase 1)Study completedNCT06082596
What this trial is testing

Study of BEBT-908 in Subjects With Advanced Hematological Tumors

Who this might be right for
Relapsed or Refractory Non-Hodgkin's LymphomaRelapsed or Refractory Multiple Myeloma
BeBetter Med Inc 32
Early research (Phase 1)Study completedNCT00608361
What this trial is testing

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more
National Cancer Institute (NCI) 80
Next Page